Teladoc (TDOC) Earnings Dates, Call Summary & Reports

12,093 Followers

Earnings Data

Report Date

Jul 28, 2026

After Close (Confirmed)

Period Ending

2026 (Q2)

Consensus EPS Forecast

-0.25

Last Year’s EPS

-0.19

Same Quarter Last Year

Analyst Consensus

Moderate Buy

Based on 22 Analysts Ratings

Earnings Call Summary

Q1 2026

Earnings Call Date:Apr 29, 2026|

% Change Since:

Earnings Call Sentiment|Positive

The call balanced clear progress on strategic priorities—Integrated Care growth and margin improvement, meaningful BetterHelp insurance momentum, AI-driven efficiency gains, and affirmed full-year guidance—against notable near-term challenges including a weakening BetterHelp cash-pay business, margin pressure, implementation timing shifts, free cash flow seasonality and lingering gross debt/convertible note risk. Execution on the insurance rollout and the transition from subscription to visit-based models are key catalysts that underpin upside; therapist capacity and near-term mix effects are the main risks to monitor.

Company Guidance

The company reiterated 2026 consolidated guidance of $2.48B–$2.58B revenue, $267M–$306M adjusted EBITDA and $130M–$170M free cash flow (midpoints unchanged), with net loss per share roughly $0.75–$1.05 and full‑year stock‑based compensation expected below $55M (down >30% vs. 2025 and >70% since 2023). Q2 consolidated guidance is $597M–$626M revenue and $55M–$67M adjusted EBITDA. Integrated Care is guided to +0.8%–+3.5% revenue growth for the year (including ~65 bps inorganic and ~60 bps FX benefit), full‑year adjusted EBITDA margin 15.1%–16.1% (midpoint ≈ +45 bps vs. 2025), and Q2 revenue -1.75% to +1.75% (including ~70 bps from prior acquisitions) with Q2 margin 14.7%–16.0% (midpoint ≈ +65 bps YoY); Q1 Integrated Care was $395M (+1.5% YoY) with $56M adjusted EBITDA (14.2% margin), membership of 101.2M and Chronic Care enrollment of 1.2M. BetterHelp 2026 revenue is guided down 6.5% to down 1.0% versus 2025, with full‑year insurance revenue $90M–$105M (up $15M from prior) and an expected exit run‑rate ≥$125M; Q2 BetterHelp revenue is guided down 11.75% to down 5.25% with Q2 insurance revenue $18M–$22M (≈+50%+ sequentially), full‑year adjusted EBITDA margin 3.0%–4.6% and Q2 margin -0.5% to +1.5% (Q1 BetterHelp: $218M revenue, -9% YoY, $2M adj. EBITDA, 0.9% margin; average paying users 361k, -9%). Q1 consolidated results were $614M revenue, $58M adjusted EBITDA (9.5% margin), net cash outflow in FCF of $26M, $751M cash on hand and net debt to trailing adjusted EBITDA <0.9x (3.6x gross debt).

Consolidated Revenue and EBITDA Beat

Q1 consolidated revenue of $614M and adjusted EBITDA of $58M (9.5% margin) both exceeded the midpoint of guidance, demonstrating better-than-expected execution.

Integrated Care Growth and Margin Expansion

Integrated Care Q1 revenue of $395M, up 1.5% year-over-year (acquisitions contributed ~170 bps). Adjusted EBITDA rose 12% YoY to $56M, with a 14.2% margin (up ~130 bps YoY) driven by revenue upside and disciplined cost management.

Membership and Chronic Care Traction

U.S. Integrated Care membership finished at 101.2M (above guidance). Chronic Care enrollment reached 1.2M, up ~1% sequentially and ~4% YoY, with multi-condition bundles adoption increasing.

BetterHelp Insurance Rollout Momentum

BetterHelp is live in 30 states + DC, credentialed/enrolled >6,000 providers, insurance contracted lives >150M (increase of 30M since year-end 2025). Insurance-covered users average ~20% more sessions in first 90 days vs cash-pay, and states live by Q3'25 show ~800 bps improvement vs cash-only markets.

BetterHelp Insurance Revenue Acceleration

BetterHelp insurance revenue was $13M in Q1 (up $6M sequentially). Total insurance-covered sessions run >14,000/week (annualized revenue run rate >$75M); company expects exit-2026 run rate of $125M+ and raised full-year insurance revenue expectation to $90M–$105M.

Operational and AI-Driven Efficiency Gains

Investments in AI and data (Pulse engine, Prism Care) delivered operational gains: AI-assisted clinical documentation produced >300,000 notes, used by >2,000 therapists across ~30,000 insurance sessions, saving ~15 minutes per session (~4M minutes saved to date). BetterHelp ad spend down 12% YoY.

Financial Position and Cost Reduction Targets

Q1 cash balance $751M; net debt to trailing adjusted EBITDA under 0.9x (gross debt 3.6x). Full-year stock-based compensation now expected below $55M (decline >30% vs 2025 and >70% since 2023). Company affirmed full-year guidance (revenue, adjusted EBITDA, free cash flow midpoints unchanged).

Teladoc (TDOC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

TDOC Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Jul 28, 2026	2026 (Q2)	-0.25 / -	-0.19	―	―	―
Apr 29, 2026	2026 (Q1)	-0.34 / -0.36	-0.53	32.08% (+0.17)
Feb 25, 2026	2025 (Q4)	-0.18 / -0.14	-0.28	50.00% (+0.14)
Oct 29, 2025	2025 (Q3)	-0.26 / -0.28	-0.19	-47.37% (-0.09)
Jul 29, 2025	2025 (Q2)	-0.26 / -0.19	-4.92	96.14% (+4.73)
Apr 30, 2025	2025 (Q1)	-0.34 / -0.53	-0.49	-8.16% (-0.04)
Feb 26, 2025	2024 (Q4)	-0.26 / -0.28	-0.17	-64.71% (-0.11)
Oct 30, 2024	2024 (Q3)	-0.28 / -0.19	-0.35	45.71% (+0.16)
Jul 31, 2024	2024 (Q2)	-0.34 / -4.92	-0.4	-1130.00% (-4.52)
Apr 25, 2024	2024 (Q1)	-0.46 / -0.49	-0.42	-16.67% (-0.07)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

TDOC Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Apr 29, 2026	$5.95	$6.06	+1.85%
Feb 25, 2026	$4.65	$5.35	+15.05%
Oct 29, 2025	$8.23	$8.74	+6.20%
Jul 29, 2025	$7.53	$7.40	-1.73%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.